Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Antipsychotic Substitution in Children (SMEAC)
NCT00910780Phase 3Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2009
- Primary completion
- Nov 2009
01
Overview
A Phase 3 trial of aripiprazole in antipsychotic-induced weight gain (AIWG), sponsored by Washington University School of Medicine. Planned start Nov 2009; status: withdrawn.
02
Drugs
aripiprazole
03
Conditions
antipsychotic-induced weight gain (AIWG)
Beyond the preview
Go deeper on NCT00910780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910780.